Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for L yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Boardwalk Pipelines EBITDA at or above $360 million | Boardwalk Pipelines' EBITDA rose to $360 million, showing solid growth. | Intact | EBITDA falls below $346 million in any quarter after 2026-Q1 | Ebitda: $1.447B FY2026-Q2; GAAP. Published target: >=360 million USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 3, 20261,447,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
L is a diversified financial company with operating businesses, including Boardwalk Pipelines and Loews Hotels. Its long-term thesis is intact, and company quality has improved, though recent financial performance is rated neutral and confidence in the overall evidence is medium.
The valuation evidence describes L as cheap versus peers, with a small expectations gap and low fragility in what is priced in. The valuation model has high confidence, but the wider business evidence does not point to a strong overall value signal.
Over the multi-year view, management has made progress on its stated priorities: pipeline earnings and hotel results improved, and the company continued its share repurchases. Near term, miss risk is rated low, but recent misses and a past deep miss remain relevant; the next guidance update is an important watch point.
The thesis depends on continued growth in pipeline contracting rates, utilization, and projects, alongside hotel rates, occupancy, and new openings. Near term, a guidance cut would be a meaningful negative, while sustained earnings strength at sector peers could support Financials sector momentum; falling interest rates are another stated risk.
For the next one to three years, L’s thesis has support from improving operating businesses and a valuation described as cheap versus peers, but results and interest-rate conditions remain key uncertainties. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Loews Corporation's published investment case. The stated target is >=1.63 USD per share. |
| Intact |
| EPS falls below $1.63 per share in next quarter |
Diluted EPS: $1.50 per share FY2026-Q3; GAAP. Published target: >=1.63 USD per share. Target period is not explicitly aligned with this observation. Nov 2, 20261.5 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Loews Hotels Adjusted EBITDA at or above $124 million | Loews Hotels boosted adjusted EBITDA 53% to $124 million. | Intact | Adjusted EBITDA falls below $81 million in any quarter after 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain PE ratio below peer median of 16.55 | The company trades cheap versus peers with a price-to-earnings ratio of 14.9. | Intact | PE ratio rises above 16.55 for sustained period | P/E (TTM): 15.44x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 202615.4373 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.